Moderna tops revenue estimates on stronger international COVID vaccine sales

Implied TYLG Analyst Target Price: $44

NASDAQ · Markets 9m ago

Look Under The Hood: SSUS Has 12% Upside

NASDAQ · Markets 9m ago

Exxon beats first-quarter earnings estimate despite hit from Iran conflict

Investing.com · News 9m ago

DTM Crosses Above Average Analyst Target

NASDAQ · Markets 9m ago

Viasat Reaches Analyst Target Price

NASDAQ · Markets 10m ago

PGJ's Underlying Holdings Imply 26% Gain Potential

NASDAQ · Markets 10m ago

APA Reaches Analyst Target Price

NASDAQ · Markets 10m ago

GTX Crosses Above Average Analyst Target

NASDAQ · Markets 10m ago

Glaukos Reaches Analyst Target Price

NASDAQ · Markets 10m ago

Newell Brands beats estimates, raises full year outlook

Investing.com · News 10m ago